• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病生物标志物、可改变的健康变量与轻度认知障碍老年人认知变化的偏最小二乘回归分析。

Partial Least Squares Regression Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognitive Change in Older Adults with Mild Cognitive Impairment.

机构信息

Department of Psychology, The Ohio State University, Columbus, OH, USA.

Centre for Addiction and Mental Health, Toronto, Canada.

出版信息

J Alzheimers Dis. 2023;93(2):633-651. doi: 10.3233/JAD-221084.

DOI:10.3233/JAD-221084
PMID:37066909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10999056/
Abstract

BACKGROUND

Prior work has shown that certain modifiable health, Alzheimer's disease (AD) biomarker, and demographic variables are associated with cognitive performance. However, less is known about the relative importance of these different domains of variables in predicting longitudinal change in cognition.

OBJECTIVE

Identify novel relationships between modifiable physical and health variables, AD biomarkers, and slope of cognitive change over two years in a cohort of older adults with mild cognitive impairment (MCI).

METHODS

Metrics of cardiometabolic risk, stress, inflammation, neurotrophic/growth factors, and AD pathology were assessed in 123 older adults with MCI at baseline from the Alzheimer's Disease Neuroimaging Initiative (mean age = 73.9; SD = 7.6; mean education = 16.0; SD = 3.0). Partial least squares regression (PLSR)-a multivariate method which creates components that best predict an outcome-was used to identify whether these physiological variables were important in predicting slope of change in episodic memory or executive function over two years.

RESULTS

At two-year follow-up, the two PLSR models predicted, respectively, 20.0% and 19.6% of the variance in change in episodic memory and executive function. Baseline levels of AD biomarkers were important in predicting change in both episodic memory and executive function. Baseline education and neurotrophic/growth factors were important in predicting change in episodic memory, whereas cardiometabolic variables such as blood pressure and cholesterol were important in predicting change in executive function.

CONCLUSION

These data-driven analyses highlight the impact of AD biomarkers on cognitive change and further clarify potential domain specific relationships with predictors of cognitive change.

摘要

背景

先前的研究表明,某些可改变的健康状况、阿尔茨海默病(AD)生物标志物和人口统计学变量与认知表现有关。然而,对于这些不同领域的变量在预测认知纵向变化方面的相对重要性,了解较少。

目的

在轻度认知障碍(MCI)的老年队列中,确定可改变的身体和健康变量、AD 生物标志物与认知变化斜率之间的新关系。

方法

从阿尔茨海默病神经影像学倡议(ADNI)中,对 123 名基线 MCI 老年人(平均年龄 73.9;SD 7.6;平均教育年限 16.0;SD 3.0)的心血管代谢风险、压力、炎症、神经营养/生长因子和 AD 病理学进行了测量。偏最小二乘回归(PLSR)——一种创建最能预测结果的组件的多元方法——用于确定这些生理变量是否对预测两年内情景记忆或执行功能变化的斜率是否重要。

结果

在两年的随访中,两个 PLSR 模型分别预测了情景记忆和执行功能变化的 20.0%和 19.6%的方差。AD 生物标志物的基线水平对情景记忆和执行功能的变化均有重要预测作用。基线教育和神经营养/生长因子对情景记忆的变化很重要,而心血管代谢变量如血压和胆固醇对执行功能的变化很重要。

结论

这些基于数据的分析强调了 AD 生物标志物对认知变化的影响,并进一步阐明了认知变化预测因素的潜在特定领域关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4052/10999056/b0ca4cdd256c/nihms-1973353-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4052/10999056/b9e87c548cac/nihms-1973353-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4052/10999056/ae1987fa5679/nihms-1973353-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4052/10999056/b0ca4cdd256c/nihms-1973353-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4052/10999056/b9e87c548cac/nihms-1973353-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4052/10999056/ae1987fa5679/nihms-1973353-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4052/10999056/b0ca4cdd256c/nihms-1973353-f0003.jpg

相似文献

1
Partial Least Squares Regression Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognitive Change in Older Adults with Mild Cognitive Impairment.阿尔茨海默病生物标志物、可改变的健康变量与轻度认知障碍老年人认知变化的偏最小二乘回归分析。
J Alzheimers Dis. 2023;93(2):633-651. doi: 10.3233/JAD-221084.
2
Partial Least Squares Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognition in Older Adults with Mild Cognitive Impairment.轻度认知障碍老年人的阿尔茨海默病生物标志物、可改变的健康变量与认知的偏最小二乘分析
J Int Neuropsychol Soc. 2022 Sep;28(8):781-789. doi: 10.1017/S1355617721001041. Epub 2021 Oct 19.
3
Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults.基线认知能力是认知正常的老年人 4 年内认知变化的最佳预测指标。
Alzheimers Res Ther. 2021 Apr 7;13(1):75. doi: 10.1186/s13195-021-00798-4.
4
The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.血管内皮生长因子在神经退行性变和认知衰退中的作用:探索与阿尔茨海默病生物标志物的相互作用
JAMA Neurol. 2015 May;72(5):520-9. doi: 10.1001/jamaneurol.2014.4761.
5
Multifactorial Modeling of Cognitive Trajectories Using an Advanced Regression Technique: Improving Our Understanding of Biomarkers and Modifiable Variables that Support Cognition.使用高级回归技术对认知轨迹进行多因素建模:提高我们对支持认知的生物标志物和可调节变量的理解。
J Alzheimers Dis. 2023;93(2):815-819. doi: 10.3233/JAD-230304.
6
Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.高 Aβ 淀粉样蛋白对轻度认知障碍和健康老年人认知的影响:对阿尔茨海默病早期检测的启示。
Neuropsychology. 2013 May;27(3):322-332. doi: 10.1037/a0032321.
7
Harnessing forgetfulness: can episodic-memory tests predict early Alzheimer's disease?利用遗忘:情景记忆测试能否预测早期阿尔茨海默病?
Exp Brain Res. 2021 Sep;239(9):2925-2937. doi: 10.1007/s00221-021-06182-w. Epub 2021 Jul 27.
8
The mediating role of neuroimaging-derived biological brain age in the association between risk factors for dementia and cognitive decline in middle-aged and older individuals without cognitive impairment: a cohort study.神经影像学衍生的生物脑龄在无认知障碍的中年和老年人痴呆风险因素与认知能力下降之间的中介作用:一项队列研究。
Lancet Healthy Longev. 2024 Apr;5(4):e276-e286. doi: 10.1016/S2666-7568(24)00025-4.
9
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.淀粉样蛋白对从临床前阿尔茨海默病到临床阿尔茨海默病的记忆和非记忆下降的影响。
Brain. 2014 Jan;137(Pt 1):221-31. doi: 10.1093/brain/awt286. Epub 2013 Oct 30.
10
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.肝酶改变与阿尔茨海默病诊断、认知、神经影像学指标和脑脊液生物标志物的关联。
JAMA Netw Open. 2019 Jul 3;2(7):e197978. doi: 10.1001/jamanetworkopen.2019.7978.

引用本文的文献

1
Neuronal and glial dysfunction, white matter hyperintensities and cognition in ageing and Alzheimer's disease.衰老和阿尔茨海默病中的神经元和神经胶质功能障碍、白质高信号与认知
Brain Commun. 2025 Feb 14;7(1):fcaf068. doi: 10.1093/braincomms/fcaf068. eCollection 2025.

本文引用的文献

1
Association of Cardiovascular Risk Trajectory With Cognitive Decline and Incident Dementia.心血管风险轨迹与认知能力下降和痴呆症发病的关联。
Neurology. 2022 May 17;98(20):e2013-e2022. doi: 10.1212/WNL.0000000000200255. Epub 2022 Apr 20.
2
Partial Least Squares Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognition in Older Adults with Mild Cognitive Impairment.轻度认知障碍老年人的阿尔茨海默病生物标志物、可改变的健康变量与认知的偏最小二乘分析
J Int Neuropsychol Soc. 2022 Sep;28(8):781-789. doi: 10.1017/S1355617721001041. Epub 2021 Oct 19.
3
Change in cognition and body mass index in relation to preclinical dementia.
与临床前痴呆症相关的认知和体重指数变化。
Alzheimers Dement (N Y). 2021 May 13;7(1):e12176. doi: 10.1002/trc2.12176. eCollection 2021.
4
Lower brain-derived neurotrophic factor levels are associated with age-related memory impairment in community-dwelling older adults: the Sefuri study.大脑源性神经营养因子水平降低与社区居住的老年成年人与年龄相关的记忆障碍有关:Sefuri 研究。
Sci Rep. 2020 Oct 5;10(1):16442. doi: 10.1038/s41598-020-73576-1.
5
Education differentially contributes to cognitive reserve across racial/ethnic groups.教育对不同种族/族裔群体的认知储备有不同的贡献。
Alzheimers Dement. 2021 Jan;17(1):70-80. doi: 10.1002/alz.12176. Epub 2020 Aug 22.
6
Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study.散发性阿尔茨海默病的临床及生物标志物轨迹:一项纵向研究
Alzheimers Dement (Amst). 2020 Aug 12;12(1):e12095. doi: 10.1002/dad2.12095. eCollection 2020.
7
Association Between Blood Pressure and Later-Life Cognition Among Black and White Individuals.血压与黑人和白人晚年认知能力的关系。
JAMA Neurol. 2020 Jul 1;77(7):810-819. doi: 10.1001/jamaneurol.2020.0568.
8
Is Blood Brain-Derived Neurotrophic Factor a Useful Biomarker to Monitor Mild Cognitive Impairment Patients?血液脑源性神经营养因子是否可作为监测轻度认知障碍患者的有用生物标志物?
Rejuvenation Res. 2020 Oct;23(5):411-419. doi: 10.1089/rej.2020.2307. Epub 2020 Apr 21.
9
Plasma amyloid is associated with the rate of cognitive decline in cognitively normal elderly: the SCIENCe project.血浆淀粉样蛋白与认知正常老年人认知衰退的速度有关:SCIENCe 项目。
Neurobiol Aging. 2020 May;89:99-107. doi: 10.1016/j.neurobiolaging.2020.01.007. Epub 2020 Jan 15.
10
Intrinsic functional connectivity, CSF biomarker profiles and their relation to cognitive function in mild cognitive impairment.内在功能连接、CSF 生物标志物谱及其与轻度认知障碍认知功能的关系。
Acta Neuropsychiatr. 2020 Aug;32(4):206-213. doi: 10.1017/neu.2019.49. Epub 2019 Dec 5.